Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-079613
Filing Date
2024-09-18
Accepted
2024-09-18 06:32:13
Documents
2
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0214959-6k_purple.htm 6-K 14901
2 PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON SEPTEMBER 18, 2024 ea021495901ex99-1_purple.htm EX-99.1 21480
  Complete submission text file 0001213900-24-079613.txt   37658
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 241306154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)